Close Menu

The Scan

In PLOS this week: improved imputation, evolution of Vibrio cholerae isolates from recent outbreak, and more.

The Tampa Bay Times reports that an investigation into foreign ties is being launched following the departure of the CEO, a vice president, and four researchers from the Moffitt Cancer Center.

Tighter Ties

ScienceInsider reports the choice of Sethuraman Panchanathan as National Science Foundation director underscores the increasing ties between the agency and the White House.

More AI

The Guardian reports GlaxoSmithKline is seeking to bolster its use of artificial intelligence in drug development.

According to Yahoo News, the Pentagon is warning members of the military that direct-to-consumer DNA testing kits might raise security risks.

Researchers have made gene-edited tomatoes that grow in bunches like grapes, as Popular Mechanics reports.

Downgraded Variant

The Wall Street Journal reports on a family whose BRCA mutation was downgraded to a variant of uncertain significance.

In PNAS this week: gene-edited mouse model of small cell lung cancer, cystic fibrosis carrier-related conditions, and more.

Nature News reports that ancient DNA researcher Alan Cooper has been dismissed from the University of Adelaide after an investigation into bullying.

Therapy Lottery

The Guardian reports that parents of children with spinal muscular atrophy are concerned about a plan to have a lottery for free gene therapy doses.

Analysis Plans

According to NHK, Japan's health ministry has announced a new plan to analyze genomic data from more than 90,000 patients.

In PLOS this week: loci linked to vitamin D metabolism, rapid diagnostic for Chagas disease, and more.

NSF Nominee Announced

Sethuraman Panchanathan from Arizona State University is to be the nominee to be the next director of the National Science Foundation.

According to E&E News, the Trump Administration is weighing an executive order to require federally funded research to be freely available upon publication.

For the Data

CNBC reports that hospitals are increasingly being approached by startups asking them to sell access to their data.

In Science this week: discussions of definition of 'human' and expression profiles of blood cells.

Psomagen is buying bankrupt microbiome testing firm uBiome's assets, Stat News reports.

The New York Times reports academic researchers often work right through the holidays and over the weekends.

Check the Aging Clock

Companies are beginning to offer epigenetic tests so people can gauge if they are aging faster or slower than the average person and make changes, according to Wired.

In Nature this week: water lily genome gives glimpse into early evolution of angiosperms, mutations in 140 genes perturb immunophenotype, and more.

A Good Spin

A new analysis in The BMJ finds that male authors are more likely to use terms like "novel," "unique," or "unprecedented" when describing their work, which leads to more citations.

Lessons to Learn

An editorial in the South China Morning Post seeks to learn from the He Jiankui gene-editing affair.

A new genome-wide association study of income has drawn criticism on Twitter.

In Nucleic Acids Research this week: 5hmC modifications coincide with malaria parasite gene expression changes, approach for clustering single-cell RNA sequences, and more.

The New York Times reports the Infectious Disease Research Institute in Seattle has laid off about a third of its researchers.


The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.